Sodium Fluoride F 18 (Mayo Clinic)
Welcome to the PulseAid listing for the Sodium Fluoride F 18 drug offered from Mayo Clinic. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayo Clinic |
| NON-PROPRIETARY NAME: | sodium fluoride F 18 |
| SUBSTANCE NAME: | SODIUM FLUORIDE F-18 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Fluoride F 18 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Fluoride F 18 from Mayo Clinic |
| LABELER NAME: | Mayo Clinic |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 91.5(mCi/mL) |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52670-550_9dc054aa-bdb5-4f1b-b52f-de093450cec0 |
| PRODUCT NDC: | 52670-550 |
| APPLICATION NUMBER: | ANDA203605 |
Other SODIUM FLUORIDE F-18 Pharmaceutical Manufacturers / Labelers:
